Cargando…

Intranasal immunization with recombinant Toxoplasma gondii actin depolymerizing factor confers protective efficacy against toxoplasmosis in mice

BACKGROUND: Toxoplasma gondii is an opportunistic protozoan closely associated with AIDS and vertical transmission. T. gondii actin depolymerizing factor (TgADF) plays an important role in actin cytoskeleton remodeling, and it is required to invade host cells. TgADF was a promising vaccine candidate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhuanzhuan, Yin, Litian, Li, Yaqing, Yuan, Fei, Zhang, Xiaofan, Ma, Jiazhi, Liu, Hongmei, Wang, Yanjuan, Zheng, Kuiyang, Cao, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053087/ https://www.ncbi.nlm.nih.gov/pubmed/27716047 http://dx.doi.org/10.1186/s12865-016-0173-9

Ejemplares similares

Intranasal Immunisation with Recombinant Toxoplasma gondii Actin Partly Protects Mice against Toxoplasmosis
por: Yin, Li-Tian, et al.
Publicado: (2013)

Intranasal immunisation with recombinant Toxoplasma gondii uridine phosphorylase confers resistance against acute toxoplasmosis in mice
por: Yin, Li-Tian, et al.
Publicado: (2023)

Actin depolymerizing factor controls actin turnover and gliding motility in Toxoplasma gondii
por: Mehta, Simren, et al.
Publicado: (2011)

Partial Protective Effect of Intranasal Immunization with Recombinant Toxoplasma gondii Rhoptry Protein 17 against Toxoplasmosis in Mice
por: Wang, Hai-Long, et al.
Publicado: (2014)

Diagnosis of toxoplasmosis and typing of Toxoplasma gondii
por: Liu, Quan, et al.
Publicado: (2015)

Toxoplasma gondii Recombinant Antigens in the Serodiagnosis of Toxoplasmosis in Domestic and Farm Animals
por: Ferra, Bartłomiej, et al.
Publicado: (2020)

Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice
por: Wang, Hai-Long, et al.
Publicado: (2016)

Evaluation of toxoplasmosis in pregnant women using dot-immunogold-silver staining with recombinant Toxoplasma gondii peroxiredoxin protein
por: Liu, Zhuan-zhuan, et al.
Publicado: (2020)

Toxoplasma gondii infection and toxoplasmosis in North Africa: a review
por: Rouatbi, Mariem, et al.
Publicado: (2019)

Cloning and expression of Toxoplasma gondii GRA-4 recombinant protein as a toxoplasmosis diagnostic kit candidate
por: Hanafiah, Muhammad, et al.
Publicado: (2020)

Genetic Divergence of Toxoplasma gondii Strains Associated with Ocular Toxoplasmosis, Brazil
por: Khan, Asis, et al.
Publicado: (2006)

A metabolite attenuates neuroinflammation, synaptic loss and cognitive deficits induced by chronic infection of Toxoplasma gondii
por: He, Yan, et al.
Publicado: (2022)

Vaccination against Murine Toxoplasmosis Using Recombinant Toxoplasma gondii SAG3 Antigen Alone or in Combination with Quil A
por: Lee, Young-Ha, et al.
Publicado: (2007)

Identification of Toxoplasma Gondii Tyrosine Hydroxylase (TH) Activity and Molecular Immunoprotection against Toxoplasmosis
por: Zhang, Zhenchao, et al.
Publicado: (2020)

Severe Acquired Toxoplasmosis Caused by Wild Cycle of Toxoplasma gondii, French Guiana
por: Carme, Bernard, et al.
Publicado: (2009)

The role of DNA microarrays in Toxoplasma gondii research, the causative agent of ocular toxoplasmosis
por: Brown, Kevin M., et al.
Publicado: (2009)

Toxoplasma gondii cathepsin proteases are undeveloped prominent vaccine antigens against toxoplasmosis
por: Zhao, Guanghui, et al.
Publicado: (2013)

Effects of Toxoplasma gondii Infection in Level of Serum Testosterone in Males with Chronic Toxoplasmosis
por: ESLAMIRAD, Zahra, et al.
Publicado: (2013)

Genotyping of Toxoplasma gondii Strains Isolated from Patients with Ocular Toxoplasmosis in Iran
por: NOROUZI, Maryam, et al.
Publicado: (2016)

Targeting Toxoplasma gondii CPSF3 as a new approach to control toxoplasmosis
por: Palencia, Andrés, et al.
Publicado: (2017)

Experimental Porcine Toxoplasma gondii Infection as a Representative Model for Human Toxoplasmosis
por: Nau, Julia, et al.
Publicado: (2017)

Toxoplasma gondii infection and toxoplasmosis in farm animals: Risk factors and economic impact
por: Stelzer, S., et al.
Publicado: (2019)

Recombinant Toxoplasma gondii Ribosomal Protein P2 Modulates the Functions of Murine Macrophages In Vitro and Provides Immunity against Acute Toxoplasmosis In Vivo
por: Yu, Zhengqing, et al.
Publicado: (2021)

Genetic Characterization of Toxoplasma gondii Isolates and Toxoplasmosis Seroprevalence in Stray Cats of İzmir, Turkey
por: Can, Hüseyin, et al.
Publicado: (2014)

Evaluation of Anti-Toxoplasma gondii Effect of Ursolic Acid as a Novel Toxoplasmosis Inhibitor
por: Choi, Won Hyung, et al.
Publicado: (2018)

Anti-Toxoplasma gondii IgG avidity testing is necessary for diagnosis of acute toxoplasmosis
por: Nasir, Idris-Abdullahi, et al.
Publicado: (2017)

Human toxoplasmosis: a systematic review for genetic diversity of Toxoplasma gondii in clinical samples
por: Hosseini, S. A., et al.
Publicado: (2018)

Immunization with Toxoplasma gondii peroxiredoxin 1 induces protective immunity against toxoplasmosis in mice
por: Fereig, Ragab M., et al.
Publicado: (2017)

Role of amylopectin synthesis in Toxoplasma gondii and its implication in vaccine development against toxoplasmosis
por: Lyu, Congcong, et al.
Publicado: (2021)

Toxoplasma gondii Protein Disulfide Isomerase (TgPDI) Is a Novel Vaccine Candidate against Toxoplasmosis
por: Wang, Hai-Long, et al.
Publicado: (2013)

Immunoreactivity Analysis of Toxoplasma gondii Recombinant Antigen rSAG3 in Sera from Immunized BALB/c Mice and Toxoplasmosis Patients
por: MOTAZEDIAN, Mohammad Hossein, et al.
Publicado: (2016)

A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis
por: Tian, Xiaowei, et al.
Publicado: (2022)

Toxoplasma gondii actin filaments are tuned for rapid disassembly and turnover
por: Hvorecny, Kelli L., et al.
Publicado: (2023)

Auranofin Is Highly Efficacious against Toxoplasma gondii In Vitro and in an In Vivo Experimental Model of Acute Toxoplasmosis
por: Andrade, Rosa M., et al.
Publicado: (2014)

Evaluation of Toxoplasma gondii B1 gene in Placental Tissues of Pregnant Women with Acute Toxoplasmosis
por: Sardarian, Khosro, et al.
Publicado: (2018)

Diagnosis of Swine Toxoplasmosis by PCR and Genotyping of Toxoplasma gondii from pigs in Henan, Central China
por: Wang, Haiyan, et al.
Publicado: (2017)

Development of Neurological Mouse Model for Toxoplasmosis Using Toxoplasma gondii Isolated from Chicken in Kenya
por: Mokua Mose, John, et al.
Publicado: (2017)

Immune response against toxoplasmosis—some recent updates RH: Toxoplasma gondii immune response
por: Sana, Madiha, et al.
Publicado: (2022)

Outbreak of toxoplasmosis associated with muscular lesions in finishing pigs caused by an atypical Toxoplasma gondii genotype
por: Piva, Manoela Marchezan, et al.
Publicado: (2022)

Protective Effect Against Toxoplasmosis in BALB/c Mice Vaccinated With Toxoplasma gondii Macrophage Migration Inhibitory Factor
por: Liu, Kang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4a91aej41cmj6teum4u89k67g7